As such, tumor cells can render them functionally incapacitated and evade anti-cancer mechanisms via shuttling of key proteins, such as p53, Rb, or other cell cycle regulators (Turner et al., 2009; Turner et al., 2013). Here, TP53 is linked to neoplasm.